Mutation analysis in dyskeratosis congenita: new dyskerin and telomerase RNA mutations and evidence for other disease loci
Autosomal dominant reticulo-endothelial iron overload associated with a three base pair deletion in the ferroportin 1 gene (SLC11A3)
Identification of a novel human glucosephosphate isomerase (GPI) variant in a patient with combined glucose-6-phosphate dehydrogenase (G6PD) deficiency
Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal haemoglobinuria (PNH)
Relative abundance of the messenger RNA of Plasmodium falciparum glucose-6-phosphate dehydrogenase in enzyme-deficient and normal Nigerian children
The effect of wild-type and modified HPA-1A recombinant antibodies on megakaryocyte precursors in culture
Acute normovolaemic haemodilution does not reduce allogeneic transfusion rate in major gastrointestinal surgery - a randomised controlled trial
Feasibility of cord blood transfusions for severe paediatric anaemia in under-resourced countries
Pegintron and ST1571 combination evaluation study (PISCES) in chronic phase chronic myeloid leukaemia
Molecular remission following treatment with STI571 for chronic myeloid leukaemia: a report from the UK571 study Group
Increased infidelity of non homologous end-joining (NHEJ) in Bloom's syndrome and myeloid leukaemias: evidence that Ku70 and/or 86 are required for increased frequency and size of deletions
Divergence of growth and survival pathways in blasts from patients with acute myeloid leukaemia: rhodamine 123 efflux is associated with apoptosis resistance and with protein kinase C zeta activation, but inversely associated with internal tandem duplication of the FLT3 gene
Prognostic significance of FLT3 ITD and D835 mutations in AML patients
Telomere shortening occurs with progression of CML and is associated with upregulation of hTERT mRNA
Platelet activation by recombinant factor VIIa in normals and inherited platelet disorders
Identification and characterisation of a functional NMDA-type neuroreceptor regulating megakaryocyte differentiation
Identification of cortactin deficiency in grey platelet syndrome
A mechanism by which ABO blood group may influence the concentration of plasma von Willebrand factor
Effect of N-acetylgalactosaminyltransferase expression on VWF synthesis and secretion in endothelial cells
Studies on the function of human P-Selectin, VCAM-1 and ICAM-1 transfected into Chinese hamster ovary (CHO) cells
Acquired haemoglobin H syndrome in Fanconi's anaemia with myelodysplastic disease
A novel strategy for diagnosis of thalassemia with unknown mutations
The binding of eosin 5′maleimide (EMA) to red cells from patients with hereditary spherocytosis
Day case pain management in a UK sickle cell unit
Poor outcome of central venous access devices (CVAD) in patients with homozygous sickle cell (SS) disease
Hereditary spherocytosis with a low temperature Na/K leak and thrombosis
Monocyte/macrophage antibacterial functions in beta-thalassaemia major
Haematologic parameters in Kala-azar
Non-interventionist management for children with acute immune thrombocytopenic purpura
Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor reactive reagents
The use of prophylactic recombinant factor VII to prevent intracranial haemorrhage in an infant with severe factor VII deficiency
Normal developmental outcome in a 2-year old child born after successful salvage of Haemoglobin Barts hydrops foetalis syndrome with multiple in utero transfusions
Ten year evaluation of selective antenatal screening for HB disorders in intermediate incidence area. Trends in service provision and effectiveness
Dendritic cells from CML patients display abnormalities in antigen processing, migration and function
Emergence of additional chromosomal abnormalities following treatment with STI571 (imatinib mesylate) for philadelphia positive chronic myeloid leukemia in chronic phase
Chronic myeloproliferative disease (MPD) with rearrangement of the platelet derived growth factor receptor beta (PDGFRB) gene showing rapid and durable response to the tyrosine kinase inhibitor STI571
Collection of peripheral blood stem cells in chronic myeloid leukaemia (CML) patients philadelphia negative after treatment with imatinib mesylate (Glivec)
Addition of ST1571 does not improve survival for patients with CML in myeloid blastic transformation
ST1571 for patients with CML in chronic phase: prognostic factors for response and benefit of G-CSF
The use of denaturing high performance liquid chromatography (DHPLC) for the detection of ABL mutations associated with clinical resistance to STI571 (Glivec)
The cytogenetic response to Glivec can be monitored by blood real time RT-PCR in chronic myeloid leukaemia
Clonal evolution in patients treated with Imantinib for CML in chronic phase
Quality of life in patients receiving high or low dose interferon-alpha therapy in chronic myeloid leukaemia (CML): a report from the MRC CML V randomised trial
Dose limiting dermatological toxicity secondary to imatinib mesylate (STI-571) in chronic myeloid leukaemia (CML)
STI571 administered in the recovery phase after autografting (auto-SCT) for CML in accelerated phase: no apparent delay in hematological recovery
A spectrum of skin reactions to the tyrosine kinase inhibitor imatinib mesylate (STI 571)
A survey of fish practice in the UK for the diagnosis and monitoring of CML
Scottish Leukaemia Registry (SLR) CML audit
Utility of apoptotic proteins as adjuvant prognostic markers for chronic myeloid leukaemia patients
Clinical implications and consequences of leukapheresis to reduce tumour burden in newly-diagnosed patients with hyperleukocytosis (HL) and acute myeloid leukaemia
Prognostic stratification in AML patients with intermediate risk cytogenetics is improved by quantitative bax and FLT3-ITD characterisation
Reduced intensity conditioned (RIC) voluntary unrelated donor transplantation (VUD) in poor risk MDS and myeloid leukaemia using Fludarabine, Busulphan and CAMPATH-1H (FBC)
A feasibility study of Mylotarg (Gemtuzumab Ozogomycin, GO) in combination with standard induced therapy in acute myeloid leukaemia (AML)
Gemtuzumab ozogamicin: is not associated with an increased risk of veno-occlusive disease in relapsed or refactory AML, when used alone or in combination with flag chemotherapy
Insulin-like growth factors and binding proteins do not appear to be implicated in the pathogenesis of classical or polyclonal ET
An evaluation of modified high-dose cytarabine (mHiDAC)-containing postremission therapy in patients over age 60 years with acute myeloid leukemia: data from the Toronto Leukemia Study Group
Lack of MMR proteins expression is detected at a higher rate in secondary and therapy-related AML and MDS patients
Imatinib mesylate (STI571) induced molecular remission of Philadelphia chromosome-positive myelodysplasia
Arsenic trioxide in the treatment of acute promyelocytic leukemia
The cell surface expression of Annexin II on various myeloid leukaemic cell lines
Role of high dose Cytarabine and Amsacrine chemotherapy in refactory and relapsed acute leukaemia: a single centre experience
Measurement of heparin levels in pregnant women to ensure safe and appropriate dosing
Thromboprohylaxis in general medical patients: low molecular weight heparin versus unfractionated heparin
Prevention of venous thromboembolism in medical patients: a meta-analysis of the clinical trials
Treatment of venous thrombosis in pregnancy using low molecular weight heparin
Venous thromboembolism in the black population
Continuous iv hirudin in cancer-associated thrombosis
Prevalence of DVT in the operated and nonoperated limb following hip arthroplasty
The oral direct thrombin inhibitor ximelagatran and its active form melagatran are efficacious and well tolerated as thromboprophylaxis after total hip or total knee replacement (THR or TKR)
Comparison of the pharmacokinetics of ximelagatran in young and elderly healthy subjects
Ethnic origin has no influence on the pharmacokinetics and pharmacodynamics of ximelagatran administered orally to healthy volunteers
Anticoagulation: the next step. A patient centred approach
Anticoagulant induced skin necrosis: association with heparin-induced thrombocytopenia and acquired protein- S deficiency due to antiphospholipid syndrome
Should adjusted dose warfarin be used in patients with metastatic colonic carcinoma on weekly infusional chemotherapy?
Reversal of warfarin overanticoagulation using a two milligramme dose of oral Konakion: a prospective study
Evidence of a temporary prothrombotic state in patients in sinus rhythm after electrical cardioversion of persistent atrial fibrillation
Evaluation of frozen plasma calibrants in a UK NEQAS (blood coagulation) supplementary exercise
Identification of system faults by monitoring of point of care testing (POCT) for INR's in primary care
A nurse led out-patient deep vein thrombosis (DVT) service, using a seven day dosing schedule for the safe and rapid initiation of warfarin anticoagulation
Commonly used algorithm (Fennerty) overanticoagulates patients after heart valve replacement surgery
Plasma protein Z and risk of venous thromboembolism in young women
Audit of management of warfarin over-anticoagulation in the Grampian area
Protein Z levels in patients with antiphospholipid antibodies, their association with anticardiolipin, lupus anticoagulant and thrombosis
INR determinations in fresh, frozen and lyophilised test samples can be influenced by optical clarity
The performance of VIDAS D-dimer in excluding pulmonary embolism
Safe warfarin induction for AF prophylaxis requiring only a weekly INR
Cytochrome P450 CYP2C9 polymorphisms in patients on a stable maintenance warfarin dose of less than 1 mg daily
Use of clinical assessment, colour-flow Doppler ultrasonography and D-dimer in the investigation of suspected deep venous thrombosis
Oral vitamin K for excessively anticoagulated patients who are not bleeding is safe and effective
Anticoagulant practitioner management of inpatient oral anticoagulant therapy is safe and reduces laboratory INR requests
What is a safe INR for dental surgery? Audit of oral anticoagulation (AC) in patients undergoing dentoalveolar surgery
Transmission of INR results by automatic voicemail: successful use of telemedicine in haematology
Randomised cross-over study of near patient testing versus hospital laboratory testing with computer assisted dosing in a community anticoagulant clinic
Endothelial dysfunction and impaired endogenous fibrinolysis do not contribute to acute stent thrombosis or in-stent restenosis
The endothelial cell Protein C receptor, in similarity with MHC class I molecules, can be upregulated by interferon gamma
Mild systemic inflammation enhances the acute endothelial fibrinolytic capacity
Tumour necrosis factor-alpha stimulates local release of tissue plasminogen activator in man
Effect of tumour necrosis factor-alpha on transcription of tissue plasminogen activator and plasminogen activator inhibitor-1
Plasminogen activators: a feature of normal myeloid differentiation or leukaemic transformation?
Increased thrombus-associated t-PA in severe sepsis: an explanation for locally enhanced fibrinolysis
The effect of aspirin on the expression of monocyte tissue factor
Reduced intensity allografts without campath: the South West experience
CD34 selection of haemopoietic stem cell grafts as prophylaxis against graft versus host disease in acute myeloid leukaemia (AML)
Immunisation after T cell depleted allogenic bone marrow transplant for S. pneumoniae and H. influenzae. Does it work?
Reduced-intensity Rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation (HSCT) for follicular lymphoma with quantitative monitoring of minimal residual disease
Impact of the number of infused CD34+ cells on the long-term outcome of myeloma patients treated with high-dose melphalan and autotransplantation
Identification and enumeration of CMV specific cytotoxic T lymphocytes
Outcome of autotransplantation in 118 adult acute myeloid leukaemia patients in first complete remission: impact of consolidation chemotherapy (CC)
Allogeneic SCT for multiple myeloma - relapses as solitary plasmacytoma may occur despite molecular remission
The correlation of vitamin D receptor gene polymorphisms with outcome in chronic phase CML patients undergoing allogeneic BMT
Reduced intensity conditioning (RIC) containing CAMPATH-1H, a comparison of sibling versus voluntary unrelated donor (VUD) haemopoietic stem cell transplantation (HSCT)
Favourable correlation of risk stratification and eortc criteria for invasive fungal infection with PCR positivity, in a blinded study of molecular diagnostic techniques in immunocompromised haematology patients
Reduced relapse rates in newly-treated myeloma patients by using peripheral blood stem cells over bone marrow as the source of stem cells for autologous transplantation: single-center experience of 435 patients treated with 200 mg/m2 melphalan (HDM)
Etoposide abrogation of the G2M cell cycle checkpoint incurs a paradoxical state of tyrosine phosphorylation of cyclin dependent kinase 1 in myeloid leukemia cell lines
The role of Smac/DIABLO in suppression of human leukaemia
Anti-sense expression of the oncogene FUS inhibits differentiation of myeloid cell lines
Targeting XIAP with DNAzymes cleaves its transcript and induces apoptosis in myeloid leukaemias
DNA repair gene polymorphisms and adult acute myeloblastic leukaemia risk
The effect of HDAC inhibitors on growth and differentiation of cells expressing an AML-ETO or PML-RARalpha fusion gene
Evaluation of a novel card based DNA/RNA archiving system (AmpliCARD™) for PCR analysis in haematological diagnostic practice
Maturation associated changes in CD52 expression by cells of the dendritic lineage
Development of a method to measure proteasome activity in leukaemic cells
Fanconi anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or to agonistic anti-Fas antibodies
Survivin-targeting DNAzymes efficiently cleave its transcripts and induce apoptosis in myeloid leukaemias
The expression of normal cellular prion protein (PrPc) differs on human and rodent peripheral blood cells
Dipalmitoyl phosphatidylcholine modulates platelet-activating factor (PAF) synthesis in monocytic cells via regulation of enzymes of the remodelling pathway
Activation of BETA2 integrin LFA-1 on B-lymphoblastoid cell line JY induces p105HEF complex formation
ATRA and TRAIL combination therapy in acute myeloid leukaemia
Dexrazoxane to delay the emergence of MDR: possible mechanisms of action
Repeated participation in the global proficiency testing program reduces the variability in hematopoietic colony enumeration
Differential expression of ataxia telangiectasia mutated (ATM) gene in human lymphoid tissues
The tyrosine kinase fusion protein TEL/PDGF beta R has opposing effects on cellular proliferation depending on its expression level
The effect of polyunsaturated fatty acids on monocyte subpopulations and intracellular cytokine production
Direct binding of antithymocyte globulin to haemopoietic stem cells in aplastic anaemia patients
The South West Region haematologists' external quality assurance (EQA) figure for morphology
Competitive RT-PCR and real time quantitative PCR: a comparison
Autoimmune haemolytic anaemia - a high risk disorder for thromboembolism
Soluble transferrin receptor (STFR); a discriminating assay for iron deficiency
Combination infusional chemotherapy for systemic AL amyloidosis
Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors
Loading doses of warfarin (days 1 and 2) for children receiving anticoagulant therapy
Modelling aplastic anaemia: dynamics of 5-fluorouracil-resistant haemopoietic stem cells during modified normal donor longterm bone marrow culture
Accuracy of aRNA amplification for microarray analysis of haemopoietic specific gene expression
Polymorphic haplotypes of TNF alpha and IL-10 predict outcome in unrelated donor stem cell transplants (UD-SCT)
Prognostic significance of real time quantitative analysis of WT1 transcripts in bone marrow harvests used for autografting in AML
Second high-dose melphalan autografts for myeloma patients relapsing after one autograft: results equivalent to tandem transplantation
Allogeneic stem-cell transplantation (allo-SCT) following reduced-intensity conditioning in MDS: 4.5 years follow-up
Late diversification in the clonal composition of CMV-specific CD8+ T cells during immune reconstitution in recipients of allogeneic haematopoietic stem cell transplants
Peripheral blood cells with the phenotype and function of myeloid dendritic cells express CD52 and are depleted during therapy with CAMPATH-1H
In vitro effects of IFNgamma and TNFalpha on bone marrow progenitor cells from aplastic anaemia patients and normal donors
Autoimmune neutropenia, cryoglobulinaemia and multiple myeloma successfully treated with CCNU, Idarubicin and Dexamethasone (CIDEX)
Neonatal haemoglobinopathy screening, a future model
Investigation of patients with night sweats in a district general hospital setting and the emergence of SBE as another cause of pseudo-lymphomal
Gender differences in adult HB concentrations
Tumour supernatant (TSN) from primary AML is anti-apoptotic and its effect is mediated by the maintenance of BCL-2 and BCL-XL levels
The role of 4-colour immunophenotyping in the diagnosis of acute myeloid leukaemia
Real time quantitative analysis of AML1/ETO fusion transcripts for detection and monitoring of minimal of residual in t(8; 21) positive AML patients
Gene array chips for defining prognosis in acute myeloid leukaemia
Sensitive real-time RT-PCR quantitation of PML-RARA transcripts can predict early relapse in APL patients
Rapid identification of the prognostic cytogenetic abnormalities t(8; 21), t(15; 17) and inv16 in acute myeloid leukaemia using 4-colour flow cytometry
Differentially expressed genes in familial myelodysplastic syndromes (MDS) as identified by microarray analysis
Microarray analysis of AML-M7 leukaemia
Telomere shortening at diagnosis correlates with prognostic score and is associated with early disease progression in CML
Quantitation of Dek/Can fusion transcript by real-time quantitative PCR in patients with T(6; 9) associated AML
Quantification of AML1-ETO transcripts in patients with acute myeloid leukaemia by transcription-mediated amplification and hybridisation protection assay
Comparison of gene expression in bone marrow samples from AML, non-AML patients and AML cell lines
An assessment of spontaneous apoptosis, bcl-2 and bax during sepsis in acute myeloid leukaemia
Microarray detection of genomic imbalances at 25 oncogene loci in the progression of chronic myeloid leukaemia
A study of comparative genomic hybridisation in essential thrombocythaemia and polycythaemia rubra vera
Cost-effectiveness of Rituximab in treatment of diffuse large B-cell lymphoma
Proliferation of acute lymphoblastic leukaemia cells in vitro and in vivo
TNF polymorphisms which result in high TNF production are associated with a poor outcome in patients with B-cell non-Hodgkin's lymphoma
A comparison between polyacrymlamide gel eletrophoresis (PAGE) and capillary electrophoresis (CE) analysis of PCR products of immunoglobulin heavy chain (IGH) and T cell receptor gamma (TCRγ) gene rearrangements in lymphoproliferative lesions
Decreasing the variables for real time assessment of MRD in childhood ALL
Interferon gamma and interleukin 10 gene polymorphisms in Hodgkin's lymphoma
PCR-based clonality studies for early diagnosis of lymphoproliferative disorders: report of the BIOMED-2 concerted action
Neutropenia and anaemia associated with T cell large granular lymphocyte leukaemia (LGL): responds to fludarabine with mineral toxicity
Characterisation of immune responses against control antigens and latent membrane protein 1 (LMP1) in Hodgkin's disease (HD)
Positron emission tomography in Hodgkin's disease with a residual mass post treatment: a single centre experience
Magnetic resonance imaging (MRI) breast screening in women at increased risk from mantle and mediastinal irradiation for Hodgkins disease - a pilot
The IGH translocation breakpoints in multiple myeloma patients involve complex recombination events which may define molecular subtypes of the disease
Dendritic cell (DC) presentation of antigens from apoptotic multiple myeloma (MM) cells: a novel method to generate specific anti-MM cytotoxic T cells
Combination therapy with thalidomide, cyclophosphamide and dexamethasone (C-ThaD) for relapsed and primary refractory multiple myeloma
Implication of impaired renal function at the time of initiation of infusional chemotherapy including cyclophosphamide (C-VAMP) in patients with newly-diagnosed myeloma
A study of the safety and efficacy of thalidomide combined with vincristine, adriamycin and dexamethasone (T-VAD) in the treatment of younger patients with multiple myeloma: a UK myeloma forum pilot study
Use of infusional chemotherapy (C-VAMP) for patients who relapse after original C-VAMP and high-dose therapy (HDT)
Relapse following complete remission: outcome predictors in patients with secretory myeloma
Administration of weekly cyclophosphamide as part of infusional induction chemotherapy (C-VAMP) does not affect subsequent peripheral blood stem cell collection in patients with myeloma
A study of the safety and efficacy of oral melphalan, prednisolone and thalidomide (MPT) in the treatment of multiple myeloma: a UK myeloma forum pilot study
Paradoxical increased complete remission (CR) rate in patients with chromosome 13 abnormalities in new patients treated with C-VAMP to maximum response
'Discontinuous complete remission': a new endpoint to evaluate the success of therapy in keeping myeloma patients disease-free for extended periods of time
Defects of the mismatch repair pathway are found in plasma cell dyscrasias
A decade of multiple myeloma on Teeside
Pre-treatment beta2microglobulin and CRP may predict response to thalidomide treatment for myeloma
Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains
Incidence and role of c-kit (CD117) and HER-2/neu overexpression detected by immunohistochemistry in patients with multiple myeloma
Determination of drug-protein interactions between interferon alpha, pegylated interferon alpha and the plasma protein alpha-1-acid glycoprotein
Interleukin (IL-) 15 protects the myeloma cell line U266 against the antiproliferative effect of dexamethasone in a dose dependent manner
The outcome of elderly patients with intermediate/high grade Non-Hodgkin's lymphoma
RE-audit of the diagnosis and treatment of Hodgkin's disease in the South West (SW) Region of England
Mononuclear cells treated by extracorporeal photopheresis do not express heat shock protein 70(72)
Splenectomy in mantle cell lymphoma with leukaemia - a comparison with chronic lymphocytic leukaemia
Incidence and role of c-kit (CD 117) overexpression in mantle cell lymphoma
B cell lymphoproliferative disorder of the elderly - further follow up and molecular analysis
Immunophenotyping in the differential diagnosis of mantie cell lymphoma/leukaemia
CD40 engagement on CLL cells increases production of vascular endothelial growth factor (VEGF) and promotes cell survival
Gene expression analysis for the 11Q abnormality in CLL
Antigen receptor non-responsiveness in chronic lymphocytic leukaemia
MMP-9 production and function in chronic lymphocytic leukaemia
The chemokine receptor CCR7 and alpha4 integrin are important for CLL-cell migration into lymph nodes
Hairy cell leukaemia: a population-based clinical review
Use of the protein tyrosine phosphatase inhibitor MPV(PIC) to enhance the cytotoxic effect of alpha interferon in hairy-cell leukaemia
CD38 expression in CLL
Campath-1H (Alemtuzumab) levels and peripheral blood CLL count predict response in refractory CLL
Expansion of T cells from lymphocytic leukaemia (CLL) patients using CD3/CD28 co-stimulation and feeder cells
Molecular analysis of a bi-clonal CLL transforming to a more aggressive state
Patient attitudes towards allogeneic transfusion and the alternatives available
Usefulness of the audit cycle to monitor the appropriateness of platelet transfusions
Transfusion medicine epidemiology pilot study
The use of granulocyte transfusions from pooled buffy coats for the treatment of infections in immunocompromised patients
Unstimulated granulocyte transfusions: a retrospective audit of practice in the northern region of England
Trisomy 9 mosaicism as an unusual cause of ABO blood group chimaerism
Rhesus D phenotyping by sensitive automated column technique and monoclonal anti-sera in routine clinical practice. Is typing by a single anti-sera clinically safe?
Latex allergy - an unusual cause of severe blood transfusion reactions
Audit in transfusion practice - can it effect change? A report from the West of Scotland Haematology Audit Group
Pre-operative transfusion in sickle cell disease: a systematic review of the evidence
The use of barcode technology to reduce the incidence of 'wrong blood' transfusions
Five years of serious hazards of transfusion (SHOT): powerful data, slow progress on implementing recommendations
Development and evaluation of denaturing high pressure liquid chromatography (DHPLC) for mutation detection in von Willebrand disease
Investigation into the efficacy of FFP to increase coagulation factor levels
Coagulation factors IX and XI are both preserved in acute liver injury
Comparison of an in-house ELISA method with the I. L. Kit (ACL 9000) for measurement of von Willebrand factor antigen
Recombinant factor VIIa in the prevention of surgical bleeding in patients with factor XI deficiency
Mild haemophilia a with discrepant one stage and chromogenic FVIII levels associated with no increment in the FVIII level post-DDAVP
Quantitation of human von Willebrand factor messenger RNA
Recombinant factor VIIa as a haemostatic agent in children with inherited platelet disorders
Misclassification of von Willebrand disease type 2M: correlation of phenotype with genotype
Reduced half life of von Willebrand factor antigen in type 1 von Willebrand syndrome compared to mild haemophilia
His1299Arg polymorphism associated with factor V deficiency
Pharmacokinetic studies: a diagnostic tool for acquired von Willebrand syndrome?
Evaluation of PFA-100 as a screening test in a group of patients referred to a tertiary haemostasis unit for investigation of a potential bleeding diathesis
Lupus anticoagulant (LA) screening; impact of national testing guidelines and reference plasmas on diagnostic accuracy
The prevalence of antibody isotypes against phospholipids and beta-2-glycoproteins in women with recurrent miscarriage
An audit of interpretation of laboratory tests for the lupus anticoagulant
Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and anti-beta2GPI antibodies
Interference in coagulation tests associated with multiple myeloma. Implications for screening for antiphospholipid antibodies
Markers of endothelial activation and atherothrombosis in women with history of preeclampsia of gestational hypertension
Favourable pregnancy outcomes in women with previous stillbirth and other late obstetric complications treated with low dose aspirin ±low molecular weight heparin
Thrombomodulin (TM) Ala455Val polymorphism and the risk of severe obstetric complications
Neonatal alloimmune thrombocytopenia in Scotland: a national HPA-1 epidemiological study involving 26 507 pregnant women
Heparin-induced thrombocytopenia; the value of laboratory testing
Asymptomatic constitutional macrothrombocytopenia among West Bengal blood donors
A retrospective review of eleven cases of thrombotic thrombocytopenic purpura (TTP) - associated deaths
Acute inflammatory effects of smoking in patients with peripheral vascular syndrome
Severity of peripheral vascular disease does not affect markers of prothrombotic state except fibrinogen
Relationship between vascular endothelial growth factor and its soluble receptor FLT-1 in peripheral vascular disease and in health: implications for angiogenesis in atherosclerosis
Vascular endothelial growth factor and tissue factor in patients with established peripheral vascular syndrome: a link between angiogenesis and thrombogenesis?
Absence of heparin cofactor II gene defects in high risk patients with recurrent miscarriage or myocardial infarction
High throughput screening for Factor V Leiden mntation using minor groove binding probes and ABi 7700 technology
The effect on tissue factor expression in leukaemic cell lines following all-trans retinoic acid induced differentiation
The prevalence of platelet glycoprotein IA/IIa gene polymorphisms C807T/G873A in patients with central retinal vein occlusion: a causal relationship
Effect of endothelial cell adhesion molecules on monocyte tissue factor expression. Implications for initiation of coagulation in disseminated intravascular coagulation
The effects of surgery and acute normovolaemic haemodilution (ANH) on coagulation as measured by the thromboelastogram
Characterisation of cell-surface procoagulant activities of T-lymphomblastoid cell lines, using three assay systems
The prothrombotic state and peripheral vascular disease: a link between tissue factor and endothelial or platelet abnormalities
Bradykinin and substance P do not cause endothelial cell tissue plasmingen activator release in vitro
Genetic polymorphisms in glutathione S-transferase P1 (GSTP1) act as a prognostic marker for multiple myeloma depending on modality of treatment
T(11; 18) is a marker for gastric MALT lymphomas that will not respond to H. pylori eradication
BCL-2 antisense induces apoptosis and enhances Rituximab activity in CLL cells
Outcome of patients with systemic AL amyloidosis in relation to circulating concentration of free immunoglobulin light-chains
Use of immunoglobulin gene rearrangement investigations in histological diagnosis of lymphoid proliferations
Eradication of detectable minimal disease with Campath-1H (Alemtuzumab) therapy results in prolonged survival in patients with refractory B-CLL
Does anticoagulation with warfarin downregulate inflammation?
Influence of cytochrome P450 CYP2C9 polymorphisms on S- and R-enantiomers of warfarin
The expression of monocyte tissue factor in patients with idiopathic venous thrombosis
Homocysteine, IL-10 and monocyte tissue factor expression in normal pregnant women
The CRP-VLDL complex underlying the biphasic APTT waveform in patients with DIC exhibits prothrombinase enhancing activity
Cyclosporin for the treatment of recurrent or refractory idiopathic adult-onset thrombotic thrombocytopenic purpura (TTP)
Epigenetic analysis of nuclear oncogene targets: chromatin fine structure and expression analysis of the macrophage colony stimulating factor receptor (c-fms) gene in normal and leukaemic cells
Increased glycogen synthase kinase-3 activity alone does not induce apoptosis in factor replete primary human erythroblasts: evidence from a tamoxifen inducible GSKb system
STI571 inhibits the activation and proliferation of normal T lymphocytes
A murine model of T-cell mediated bone destruction
Gene expression profiling in polycythemia rubra vera using cDNA microarray technology
Gene expression analysis of AML-ETO cells exposed to HDAC inhibitors - a cDNA array study